You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma

Citation Tools

Article menu
Clinical/translational cancer immunotherapy
Original research
Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chuntova P, Yamamichi A, Chen T, et al
Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma
Journal for ImmunoTherapy of Cancer 2022;10:e004644. doi: 10.1136/jitc-2022-004644